These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4333 related articles for article (PubMed ID: 29967350)
1. Mechanisms of NAFLD development and therapeutic strategies. Friedman SL; Neuschwander-Tetri BA; Rinella M; Sanyal AJ Nat Med; 2018 Jul; 24(7):908-922. PubMed ID: 29967350 [TBL] [Abstract][Full Text] [Related]
2. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. Barritt AS; Gitlin N; Klein S; Lok AS; Loomba R; Malahias L; Powell M; Vos MB; Weiss LM; Cusi K; Neuschwander-Tetri BA; Sanyal A Contemp Clin Trials; 2017 Oct; 61():33-38. PubMed ID: 28735109 [TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of and major animal models used for nonalcoholic fatty liver disease. Jiang M; Wu N; Chen X; Wang W; Chu Y; Liu H; Li W; Chen D; Li X; Xu B J Int Med Res; 2019 Apr; 47(4):1453-1466. PubMed ID: 30871397 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. Zhou JH; Cai JJ; She ZG; Li HL World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425 [TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease - current status and future directions. Demir M; Lang S; Steffen HM J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351 [TBL] [Abstract][Full Text] [Related]
9. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Takahashi Y; Fukusato T World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438 [TBL] [Abstract][Full Text] [Related]
10. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH. Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280 [TBL] [Abstract][Full Text] [Related]
11. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986 [TBL] [Abstract][Full Text] [Related]
12. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease. Crespo M; Lappe S; Feldstein AE; Alkhouri N Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease. Satapathy SK; Sanyal AJ Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640 [TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Noureddin M; Mato JM; Lu SC Exp Biol Med (Maywood); 2015 Jun; 240(6):809-20. PubMed ID: 25873078 [TBL] [Abstract][Full Text] [Related]
16. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Oates JR; McKell MC; Moreno-Fernandez ME; Damen MSMA; Deepe GS; Qualls JE; Divanovic S Front Immunol; 2019; 10():2893. PubMed ID: 31921154 [TBL] [Abstract][Full Text] [Related]
19. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017]. Nan YM; Fu N; Li WC; Kong LL; Yuan XW; Zhang SY; Liu LD; Lu Y; Cui LY Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):687-694. PubMed ID: 29108191 [TBL] [Abstract][Full Text] [Related]
20. New drugs for NAFLD: lessons from basic models to the clinic. Reimer KC; Wree A; Roderburg C; Tacke F Hepatol Int; 2020 Jan; 14(1):8-23. PubMed ID: 31802390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]